e-learning
resources
Vienna 2009
Monday, 14.09.2009
Management of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of somatostatin analogues in combination to antineoplastic agents in the treatment of SCLC patients (preliminary findings)
E. Eleftheriadou, G. Gerasimou, P. Zarogoulidis, C. Gioka, G. Balassoulis, I. Sapardanis, T. Kontakiotis, A. Gotzamani-Psarrakou, N. Karatzas, K. Zarogoulidis (Exohi, Thessaloniki, Thessaloniki, Greece)
Source:
Annual Congress 2009 - Management of thoracic malignancies
Session:
Management of thoracic malignancies
Session type:
Thematic Poster Session
Number:
2621
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Eleftheriadou, G. Gerasimou, P. Zarogoulidis, C. Gioka, G. Balassoulis, I. Sapardanis, T. Kontakiotis, A. Gotzamani-Psarrakou, N. Karatzas, K. Zarogoulidis (Exohi, Thessaloniki, Thessaloniki, Greece). The role of somatostatin analogues in combination to antineoplastic agents in the treatment of SCLC patients (preliminary findings). Eur Respir J 2009; 34: Suppl. 53, 2621
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The activity and toxicity of gemcitabine and paclitaxel in previously treated patients with small cell lung cancer (SCLC); preliminary results
Source: Eur Respir J 2004; 24: Suppl. 48, 301s
Year: 2004
The loss of pulmonary barrier function as a result of application of anticancer agents paclitaxel, 2-methoxyestradiol, and their combination
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Lung disease induced by novel chemotherapeutic agents and biomolecules
Source: Annual Congress 2006 - Drug-induced lung injury – new aspects
Year: 2006
Predictive role of
MMP-2
genetic variants on severe hematologic toxicity of NSCLC patients treated with first-line, platinum-based chemotherapy
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011
The clinical characteristics and treatment responses of tuberculosis in patients with malignancy on anti-cancer chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005
Emerging prognostic biomarkers in non small cell lung cancer patients: Impact of treatment with nimesulide (COX-2 inhibitor) combined with chemotherapy
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
The effect of anti-tuberculosis chemotherapy using second-line drugs on the structural and functional state of the thyroid gland
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Dynamic monitoring of plasma DAMP proteins during various anticancer agents in advanced lung cancer patients
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Potential role of antidepressants as part of anticancer therapy
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011
Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practice
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Comparative study of therapeutic effects of combination chemotherapy including various doses of clarithromycin for pulmonary
Mycobacterium avium
complex disease
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Short-term efficacy of advanced NSCLC patients receiving anlotinib hydrochloride as the first and second-line treatment
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
The possibility of strengthening of activity of antituberculous drugs: preliminary results
Source: Annual Congress 2004 - Management of tuberculosis
Year: 2004
Relapsed NSCLC and SCLC: benefits and limitations of systemic treatments beyond the second line
Source: International Congress 2017 – Rational strategies for specific treatment situations in lung cancer
Year: 2017
A preliminary study on targeted therapies in advanced lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Novel anti-angiogenic pharmacotherapy strategies
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005
Topotecan in combination with carboplatin and etoposide as first line treatment in SCLC patients: a phase I/II study – final results
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept